Project/Area Number |
21591118
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Neurology
|
Research Institution | Wakayama Medical University |
Principal Investigator |
MIWA Hideto 和歌山県立医科大学, 医学部, 准教授 (50231626)
|
Co-Investigator(Kenkyū-buntansha) |
NAKANISHI Ichiro 和歌山県立医科大学, 医学部, 助教 (40364088)
近藤 智善 和歌山県立医科大学, 医学部, 教授 (50103891)
|
Co-Investigator(Renkei-kenkyūsha) |
KONDO Tomoyoshi 和歌山県立医科大学, 医学部, 教授 (50103891)
|
Project Period (FY) |
2009 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2010: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2009: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | ゾニザミド / 振戦 / パーキンソン病 / T型カルシウムチャンネル / ゾニサミド / ドパミン / ハルマリン / モノアミン酸化酵素 |
Research Abstract |
Zonisamide is an anti-epileptic drug, and it can be used for treatment of Parkinson disease(PD). However, the pharmacological mechanisms underlying the anti-parkinsonian effects remain unclear. In the present study, we performed animal experiments using experimental tremor models, and could obtain data suggesting that not only zonisamide but also the other T-type calcium channel blockers have the anti-tremor effect. It is expected that T-type calcium channel would be a new therapeutic target of tremors.
|